Real-Time PCR Detection Kit for Infectious Bursal Disease Virus

• Customization: Available
• Type: Detection Kit
• Syringe: Plastic Syringe
• Model NO.: IBD PCR
• Blood Sampling Needle: N/a
• Breathing Pattern: N/a
• Animal Anesthesia Machine Control Method: N/a
• Shelf Life: 12 Months
• Temperature: -20
• Freezing and Thawing: Less Than 3 Times
• Applicable: All PCR Instrument
• GMP: 15074
• Transport Package: Air Way/Sea Way
• Specification: 50 kits/box
• Trademark: SINDER
• Origin: Zhucheng City, China
• HS Code: 3822001010
• Production Capacity: 50000box/Year
• Package Size: 1.00cm * 1.00cm * 1.00cm
• Package Gross Weight: 0.050kg

Product Description

Detection Kit for Infectious Bursal Disease Virus RNA(PCR-Fluorescence Probing)

ProductName  Real-time PCR Detection Kit for Infectious Bursal Disease Virus
Package  50 kits/box
Indication  The Real-time PCR Detection Kit for Infectious Bursal Disease Virus is applicable to detect the Infectious Bursal Disease Virus RNA in avian throat swab, cloaca swab, tissue, chicken embryo allantoic fluid and cell culture. The test results are for research purpose only and not for clinical diagnosis.
Main components and content

Name	Specification	Quantity
IBDV Reaction Solution	1000µl/Tube	1
IBDV Positive Control	250µl/Tube	1
Negative Control	250µl/Tube	1

Storage and Shelf Life
Stored at -20±5ºC,Repeated freezing and thawing ≤ 3 times, the shelf life is 12 months.
Test Method

1.Nucleic Acid Extraction

Commercialized RNA extraction kit can be carried out for nucleic acid extraction, please follow the instruction of the kit.

2.PCR amplification

2.1 Calculate the number of test samples, take n+2 PCR reaction tubes, and add 20µl to of reaction solution to each tube.
2.2 Add 2µl nucleic acid of negative control, positive control and nucleic acid samples into the above PRC reaction tubes respectively, centrifuge at 8000rpm for several seconds, and put them into the fluorescent quantitative PCR amplifier.
3. qR-T-PCR amplification
3.1 Selection of Fluorescence channel
Reporter Dye1: select the FAM channel to detect MS-H vaccine strain, Quencher Dye: NONE
Reporter Dye2: select the VIC or HEX channel to detect the MS wild virus strain, Quencher Dye2: NONE, passive reference: NONE. Refer to the instrument manual for other instruments.
3.2 The reaction conditions are set as:

Parameters of amplification
System	Total volume is 25µl
Reaction Conditions of PCR	Phase	Conditions	Cycles
	Pre-denaturation	95ºC for 5 minutes	1
	PCR	95ºC for 10 seconds	40
		60ºC for 30 seconds (Collect the fluorescence channel at the end of this phase)

Interpretation of the results

1.The following requirements shall be matched at the same time in one experiment, otherwise the experiment is invalid and needs to be repeated.

1.1 Positive Control: The Ct value of the FAM channel ≤ 32, and the amplification curve has a significant exponential growth phase.
1.2 Negative Control: FAM channel has no amplification curve, or the amplification curve is a straight line or slightly oblique line.
2.
If the FAM detection channel of the test sample has no amplification curve, it can be determined as IBD negative.
If the FAM detection channel has an exponential growing amplification curve and the Ct value is ≤ 36, it can be determined as IBD positive.
36<Ct Value<40 samples should be considered as doubtful results, and the analysis should be repeated for confirmation.
Precautions

1. The laboratory management shall be in strict accordance with the management specification of PCR gene amplification laboratory. The laboratory personnel must be trained professionally. The experiment process shall be conducted strictly in different areas (Reagent preparation area, specimen preparation area, amplification and product analysis area). All consumables shall be disposable after sterilization. Special apparatus, equipment and supplies at each stage of the experiment operation shall not be cross-used.
2. Please prepare the biological safety cabinet for reagent and specimen preparation stage. The Lab coat, disposable gloves and pipette shall be carried out during the experiment.
3. Repeated freezing&thawing of reagents shall be avoided as far as possible. Before use, the reagents shall be completely thawed and centrifuged at 8000rpm for several seconds.
4. Please put the pipette used in the specimen preparation area into the container containing disinfectant and discard with the waste after sterilization.
5. After the experiment, the worktable and pipette shall be treated with 10% hypochlorite or 75% alcohol or ultraviolet lamp.

Manufacture
Name: Shandong Xinda Gene Technology Co., Ltd
A subsidiary of the Shandong Sinder Technology Co., Ltd
Address: Building B2, Bandaohuigu Industrial Park, Shungeng Road, Zhucheng City, Shandong Province
Post Code: 262233
Phone: +86 - 0532 5882 0810

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.